Search Results

There are 9948 results for: content related to: Doxorubicin loading, release, and stability of polyamidoamine dendrimer-coated magnetic nanoparticles

  1. A novel calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine overcomes multidrug resistance in drug-resistant MCF-7/ADR breast carcinoma cells

    Journal of Pharmaceutical Sciences

    Volume 99, Issue 7, July 2010, Pages: 3266–3275, Rong Liu, Yanjun Zhang, Yanhong Chen, Jing Qi, Simei Ren, Ming Yang Xushi, Chunzheng Yang, Huifang Zhu and Dongsheng Xiong

    Version of Record online : 28 JAN 2010, DOI: 10.1002/jps.22082

  2. You have free access to this content
    Review: doxorubicin delivery systems based on chitosan for cancer therapy

    Journal of Pharmacy and Pharmacology

    Volume 61, Issue 2, February 2009, Pages: 131–142, Mei Lin Tan, Peter F.M. Choong and Crispin R. Dass

    Version of Record online : 8 JAN 2010, DOI: 10.1211/jpp.61.02.0001

  3. pH-Dependent Anticancer Drug Release from Silk Nanoparticles

    Advanced Healthcare Materials

    Volume 2, Issue 12, December, 2013, Pages: 1606–1611, F. Philipp Seib, Gregory T. Jones, Jelena Rnjak-Kovacina, Yinan Lin and David L. Kaplan

    Version of Record online : 26 APR 2013, DOI: 10.1002/adhm.201300034

  4. You have free access to this content
    Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists

    British Journal of Pharmacology

    Volume 170, Issue 5, November 2013, Pages: 1137–1151, Kenneth K W To and Brian Tomlinson

    Version of Record online : 15 OCT 2013, DOI: 10.1111/bph.12367

  5. You have free access to this content
    Poster Presentations

    The FEBS Journal

    Volume 273, Issue s1, June 2006, Pages: 77–367,

    Version of Record online : 8 JUN 2006, DOI: 10.1111/j.1742-4658.2006.05277.x

  6. Inhibition of Multidrug Resistance of Cancer Cells by Co-Delivery of DNA Nanostructures and Drugs Using Porous Silicon Nanoparticles@Giant Liposomes

    Advanced Functional Materials

    Volume 25, Issue 22, June 10, 2015, Pages: 3330–3340, Feng Kong, Xu Zhang, Hongbo Zhang, Xiangmeng Qu, Dong Chen, Mark Servos, Ermei Mäkilä, Jarno Salonen, Hélder A. Santos, Mingtan Hai and David A. Weitz

    Version of Record online : 27 APR 2015, DOI: 10.1002/adfm.201500594

  7. Proteomic approaches for investigation of therapy resistance in cancer

    PROTEOMICS - Clinical Applications

    Volume 3, Issue 8, August 2009, Pages: 883–911, Hermann Lage

    Version of Record online : 18 AUG 2009, DOI: 10.1002/prca.200800162

  8. Smart pH-Responsive Nanocarriers Based on Nano-Graphene Oxide for Combined Chemo- and Photothermal Therapy Overcoming Drug Resistance

    Advanced Healthcare Materials

    Volume 3, Issue 8, August, 2014, Pages: 1261–1271, Liangzhu Feng, Kunyang Li, Xiaoze Shi, Min Gao, Jian Liu and Zhuang Liu

    Version of Record online : 20 MAR 2014, DOI: 10.1002/adhm.201300549

  9. 5-FdUrd–araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2

    Differentiation

    Volume 74, Issue 9-10, December 2006, Pages: 488–498, Stephen Strasser, Susanne Maier, Christina Leisser, Philipp Saiko, Sibylle Madlener, Yvonne Bader, Astrid Bernhaus, Marieta Gueorguieva, Susanne Richter, Robert M. Mader, Jozefa Wesierska-Gadek, Herbert Schott, Thomas Szekeres, Monika Fritzer-Szekeres and Georg Krupitza

    Version of Record online : 24 AUG 2006, DOI: 10.1111/j.1432-0436.2006.00082.x

  10. Selective Killing of Breast Cancer Cells by Doxorubicin-Loaded Fluorescent Gold Nanoclusters: Confocal Microscopy and FRET

    ChemPhysChem

    Volume 17, Issue 2, January 18, 2016, Pages: 253–259, Shyamtanu Chattoraj, Asif Amin, Batakrishna Jana, Saswat Mohapatra, Dr. Surajit Ghosh and Prof. Dr. Kankan Bhattacharyya

    Version of Record online : 4 DEC 2015, DOI: 10.1002/cphc.201500982

  11. High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells

    International Journal of Cancer

    Volume 58, Issue 3, 1 August 1994, Pages: 400–406, Kapil Mehta

    Version of Record online : 17 JUL 2006, DOI: 10.1002/ijc.2910580316

  12. Serum Proteins as Drug Carriers of Anticancer Agents

    Drug Delivery in Oncology: From Basic Research to Cancer Therapy

    Felix Kratz, Andreas Wunder, Bakheet Elsadek, Pages: 747–803, 2011

    Published Online : 16 DEC 2011, DOI: 10.1002/9783527634057.ch24

  13. You have free access to this content
    Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness

    International Journal of Cancer

    Volume 72, Issue 6, 17 September 1997, Pages: 1129–1136, Søren S. Larsen, Mogens W. Madsen, Bettina L. Jensen and Anne E. Lykkesfeldt

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-0215(19970917)72:6<1129::AID-IJC31>3.0.CO;2-X

  14. Multifunctional RbxWO3 Nanorods for Simultaneous Combined Chemo-photothermal Therapy and Photoacoustic/CT Imaging

    Small

    Volume 10, Issue 20, October 29, 2014, Pages: 4160–4170, Gan Tian, Xiao Zhang, Xiaopeng Zheng, Wenyan Yin, Longfei Ruan, Xiaodong Liu, Liangjun Zhou, Liang Yan, Shoujian Li, Zhanjun Gu and Yuliang Zhao

    Version of Record online : 30 JUN 2014, DOI: 10.1002/smll.201401237

  15. Increased epidermal growth factor receptor in an estrogen-responsive, adriamycin-resistant MCF-7 cell line

    Journal of Cellular Physiology

    Volume 157, Issue 1, October 1993, Pages: 110–118, Bruce Dickstein, Eva M. Valverius, Katja Wosikowski, Miguel Saceda, Jack W. Pearson, Mary Beth Martin and Susan E. Bates

    Version of Record online : 4 FEB 2005, DOI: 10.1002/jcp.1041570115

  16. You have free access to this content
    Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells

    International Journal of Cancer

    Volume 67, Issue 5, 4 September 1996, Pages: 608–614, Besim Ogretmen and Ahmad R. Safa

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-0215(19960904)67:5<608::AID-IJC3>3.0.CO;2-Y

  17. You have free access to this content
    Subject Index

    Proteomics in Drug Research

    Michael Hamacher, Katrin Marcus, Kai Stühler, André van Hall, Bettina Warscheid, Helmut E. Meyer, Pages: 337–362, 2006

    Published Online : 6 JUN 2006, DOI: 10.1002/3527608230.indsub

  18. You have full text access to this Open Access content
    mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels

    Cancer Science

    Volume 99, Issue 10, October 2008, Pages: 1992–2003, Sandra E. Ghayad, Ivan Bieche, Julie A. Vendrell, Celine Keime, Rosette Lidereau, Charles Dumontet and Pascale A. Cohen

    Version of Record online : 14 OCT 2008, DOI: 10.1111/j.1349-7006.2008.00955.x

  19. pH-Triggered Micelles for Tumor Delivery

    Drug Delivery in Oncology: From Basic Research to Cancer Therapy

    Haiqing Yin, You Han Bae, Pages: 1099–1131, 2011

    Published Online : 16 DEC 2011, DOI: 10.1002/9783527634057.ch34

  20. You have free access to this content
    A shift from normal to high glucose levels stimulates cell proliferation in drug sensitive MCF-7 human breast cancer cells but not in multidrug resistant MCF-7/ADR cells which overproduce PKC-βII

    International Journal of Cancer

    Volume 83, Issue 1, 24 September 1999, Pages: 98–106, Mayumi Yamamoto, Niketa A. Patel, Jennifer Taggart, Rajagopalan Sridhar and Denise R. Cooper

    Version of Record online : 10 NOV 1999, DOI: 10.1002/(SICI)1097-0215(19990924)83:1<98::AID-IJC18>3.0.CO;2-V